Abstract
We tested 102 Campylobacter jejuni and 6 Campylobacter coli clinical isolates from Poland. All were susceptible to erythromycin. Among the tested C. jejuni isolates 55.9% and 13.7% were resistant to ciprofloxacin and tetracycline, respectively. Replacement of Thr86 with Ile in GyrA and a plasmid-borne tet(O) gene were the main resistance mechanisms for fluoroquinolones and tetracycline, respectively.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Anti-Bacterial Agents / pharmacology
-
Campylobacter Infections / microbiology
-
Campylobacter coli / drug effects*
-
Campylobacter jejuni / drug effects*
-
DNA Gyrase / genetics
-
DNA, Bacterial / genetics
-
Drug Resistance, Bacterial*
-
Electrophoresis, Polyacrylamide Gel
-
Feces / microbiology
-
Humans
-
Microbial Sensitivity Tests
-
Plasmids / genetics
-
Poland
-
Polymorphism, Restriction Fragment Length
-
Tetracycline Resistance
Substances
-
Anti-Bacterial Agents
-
DNA, Bacterial
-
DNA Gyrase